论文部分内容阅读
目的：分析胎膜早破型先兆早产患者应用利托君治疗的临床效果。方法纳入本院2014年———2015年期间收治确诊为胎膜早破型先兆早产患者260例为本次研究对象，根据其接受相关治疗方案具体差异为标准以每组130例分为对照组（常规胎膜早破型先兆早产治疗）和观察组（常规治疗联合利托君治疗）。比较不同治疗方案下患者各项临床情况。结果记录患者治疗后宫缩消失时间、孕龄延长时间，观察组患者指标显示相对对照组更具优越性，统计学处理提示有意义（P＜0．05）；观察组保胎成功率、孕周到35周例数以及新生儿窒息例数等数据明显优于对照组，统计学处理提示有意义（P＜0．05）；2组均无出现严重不良反应，在耐受范围内，经处理后得到缓解。结论胎膜早破型先兆早产患者用盐酸利托君治疗能够在更短时间内发挥药效，有较高的保胎成功率，显著延长孕龄时间且安全性令人满意，值得推广。“,”Objective to analyze the clinical ef ect of premature rupture of membranes of patients with threatened preterm labor ritodrine treatment application.Methods into the 2014 and 2015 were diagnosed during caul early broken threatened preterm patients 260 cases as the research object,according to its acceptance of the relevant treatment specific dif erences as the stand-ard by a group of 130 points as control group(conventional caul early broken threatened preterm treatment)and the observation group(conventional treatment combined with ritodrine treat-ment).Compare the clinical situation of patients with dif erent treatment options.Results patients in the treatment of uterine contraction disappearance time,gestational age,the extension of time,the patients in the observation group indicators relative to the control group has more advantages,statistical analysis showed significant(P<0.05);observation group success rate of mis-carriage,gestational weeks to 35 weeks)and neonatal asphyxia cases data is significantly bet er than the control group,statistical analysis showed significant(P<0.05);group 2 had no serious adverse reactions occur,in the tolerance range,after treatment eased.Conclusion premature rupture of membranes(PROM)threatened preterm patients treated with ritodrine hydrochloride can in a shorter period of time to play a pharmacodynamics,has a higher success rate of miscarriage and prolong gestational age of time and safety is satisfactory.It is worth popularizing.